8-K: BioSig Technologies Notified of Nasdaq Minimum Bid Price Deficiency

BioSig Technologies has received a notification from Nasdaq stating that it does not meet the minimum bid price requirement of $1.00 per share.

Summary

• BioSig Technologies received a notification from Nasdaq on October 24, 2024, stating that the company's stock price did not meet the minimum bid price of $1.00 per share.
• This deficiency is based on the closing bid price of the company's common stock from June 11, 2024, through October 23, 2024.
• Nasdaq has provided BioSig a 180-day compliance period to regain compliance.
• To regain compliance, the company's stock price must close at or above $1.00 for a minimum of ten consecutive business days.
• If the company does not regain compliance within the initial 180-day period, it may be eligible for an additional compliance period.
• To qualify for the additional time, BioSig must meet the continued listing requirement for market value of publicly held shares and all other initial listing standards, except for the bid price requirement.
• The company may need to effect a reverse stock split to cure the deficiency during the second compliance period.

Sentiment

Score: 3

Explanation: The document indicates a negative development with the company's stock price falling below the minimum bid price, which could lead to delisting. The company has a period to rectify the situation, but the overall tone is concerning.

Positives

• BioSig has been granted a 180-day period to regain compliance with Nasdaq's minimum bid price requirement.
• The company may be eligible for an additional compliance period if it meets certain conditions.

Negatives

• BioSig Technologies has been notified that it does not meet the minimum bid price requirement of $1.00 per share.
• The company's stock price has been below the required minimum for a significant period.

Risks

• If BioSig fails to regain compliance within the given timeframes, it could face delisting from the Nasdaq Capital Market.
• The company may need to undertake a reverse stock split, which could negatively impact shareholder value.
• The continued low stock price may affect investor confidence and the company's ability to raise capital.

Future Outlook

BioSig Technologies must regain compliance with Nasdaq's minimum bid price requirement within the given timeframes to avoid potential delisting. The company may need to consider a reverse stock split if the stock price does not recover.

Management Comments

• Anthony Amato, Chief Executive Officer, signed the report on behalf of BioSig Technologies.

Industry Context

Minimum bid price deficiencies are not uncommon for companies listed on exchanges like Nasdaq, particularly for smaller or growth-stage companies. This situation highlights the importance of maintaining a healthy stock price to meet listing requirements.

Comparison to Industry Standards

• Many small-cap and biotech companies face similar challenges in maintaining minimum bid prices on exchanges like Nasdaq.
• Companies like Agenus Inc. (AGEN) and Ocugen, Inc. (OCGN) have also faced similar delisting warnings in the past, highlighting the commonality of this issue in the biotech sector.
• The 180-day compliance period is a standard procedure for Nasdaq, providing companies with a defined timeframe to address the deficiency.

Stakeholder Impact

• Shareholders may experience a decline in the value of their investment due to the low stock price and potential delisting.
• The company's ability to raise capital may be negatively impacted.
• Employees may be concerned about the company's future prospects.

Next Steps

• BioSig Technologies must achieve a closing bid price of at least $1.00 for ten consecutive business days within the 180-day compliance period.
• The company may need to consider a reverse stock split if the stock price does not recover.
• BioSig must meet the continued listing requirement for market value of publicly held shares and all other initial listing standards, except for the bid price requirement, to qualify for an additional compliance period.

Key Dates

Keywords

Nasdaq, minimum bid price, compliance, stock price, reverse stock split, delisting, BSGM